Integrating Bioanalytical Automation, Biomarkers, Pharmacogenomics, & Cost-Effective Strategies
Conversations in Drug Development Trends
JANUARY 6, 2025
Transforming Drug Development with Biomarkers and Streamlined Regulatory Pathways The growing focus on addressing unmet medical needs has prompted regulatory agencies to streamline pathways to expedite access to transformative therapies. As a cornerstone of the 4P model, PGx plays a transformative role in advancing personalized care.
Let's personalize your content